Suppr超能文献

从神经病理性疼痛评分估算基于偏好的 EQ-5D 健康状态效用或项目反应。

Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores.

机构信息

Pharmerit International, Bethesda, MD 20814, USA.

出版信息

Patient. 2012;5(3):185-97. doi: 10.1007/BF03262491.

Abstract

BACKGROUND

Preference-based health state utilities are required for many health economic evaluations. When the direct evidence of such is lacking and only condition-specific scores are available, establishing a 'mapping' relationship between instruments can be useful.

OBJECTIVE

Our objective was to map the 11-point Pain Intensity Numerical Rating Scale (PI-NRS-11), a pain-specific instrument ranging from 0 ('no pain') to 10 ('pain as bad as you can imagine'), to the EQ-5D, a preference-based generic instrument.

METHODS

We used web survey data collected from adult US respondents who (i) had ≥ 3 months of neuropathic pain (NP), either painful diabetic peripheral neuropathy (pDPN) or post-herpetic neuralgia (PHN); (ii) were receiving medications treating NP; and (iii) had completed the EQ-5D and PI-NRS-11. We explored indirect and direct mapping approaches. The indirect method took a probabilistic approach using ordered logistic models (OLMs) predicting response levels for each EQ-5D item via repeated Monte Carlo simulations before computing utilities. The direct approach simply predicted EQ-5D utilities directly using ordinary least squares (OLS). Categorical scores of PI-NRS-11 were used as the predictors. Patient age, gender, and pain duration were additionally controlled in the full model specification. Seventy percent of the data were used for estimation and 30% for prediction. Mean square errors (MSEs) and 95% confidence intervals (CIs) of prediction errors were reported.

RESULTS

A total of 2719 respondents were included. Mean (SD) age was 55.48 (10.65) years and 56.23% were female. Average NP duration was 61 months and 58% gave scores ≥ 6 on the PI-NRS-11. The clinical pain scores were significantly associated with all EQ-5D items, especially with the 'pain/discomfort' item (p  <  0.001). The observed mean (SD) EQ-5D index was 0.594 (0.22). Predicted utilities and responses showed good representation of the observed ones. The reduced model showed comparable results with the full model while imposing minimum data collection burden. From the reduced model, the predicted mean (SD) EQ-5D index was 0.594 (0.11) from direct estimation and 0.588 (0.19) from indirect estimation. All estimated utilities discriminated health gains/losses along the PI-NRS-11. Lower MSEs and prediction errors were found for EQ-5D >0.2.

CONCLUSIONS

Findings suggest that EQ-5D utilities or item responses could be estimated on the basis of NP scores. Independent testing of the external validity of the mapping algorithms developed herein is encouraged.

摘要

背景

许多健康经济评估都需要偏好加权健康状态效用。当直接证据缺乏且仅有特定条件的评分可用时,建立仪器之间的“映射”关系可能会很有用。

目的

我们的目的是将 11 点疼痛强度数字评定量表(PI-NRS-11)映射到 EQ-5D,这是一种从 0(“无疼痛”)到 10(“您能想象到的最严重疼痛”)的特定于疼痛的仪器,用于偏好加权通用仪器。

方法

我们使用从患有≥3 个月神经病理性疼痛(NP)的美国成年受访者那里收集的网络调查数据,这些受访者(i)患有糖尿病周围神经病变性疼痛(pDPN)或带状疱疹后神经痛(PHN);(ii)正在接受治疗 NP 的药物;(iii)已完成 EQ-5D 和 PI-NRS-11。我们探索了间接和直接映射方法。间接方法采用概率方法,使用有序逻辑模型(OLM)通过重复蒙特卡罗模拟预测每个 EQ-5D 项目的反应水平,然后计算效用。直接方法使用普通最小二乘法(OLS)直接预测 EQ-5D 效用。PI-NRS-11 的分类评分用作预测因子。在完整模型规范中,还额外控制了患者年龄、性别和疼痛持续时间。将 70%的数据用于估计,30%的数据用于预测。报告预测误差的均方误差(MSE)和 95%置信区间(CI)。

结果

共纳入 2719 名受访者。平均(SD)年龄为 55.48(10.65)岁,56.23%为女性。NP 平均持续时间为 61 个月,58%的人在 PI-NRS-11 上的评分≥6。临床疼痛评分与所有 EQ-5D 项目均显著相关,尤其是与“疼痛/不适”项目(p <0.001)。观察到的平均(SD)EQ-5D 指数为 0.594(0.22)。预测的效用和反应很好地代表了观察结果。与完整模型相比,简化模型在施加最小数据收集负担的同时显示出可比的结果。从简化模型中,直接估计的平均(SD)EQ-5D 指数为 0.594(0.11),间接估计的平均(SD)EQ-5D 指数为 0.588(0.19)。所有估计的效用都能区分 PI-NRS-11 上的健康收益/损失。EQ-5D>0.2 的情况下,MSE 和预测误差较低。

结论

研究结果表明,可以根据 NP 评分估计 EQ-5D 效用或项目反应。鼓励对本文开发的映射算法的外部有效性进行独立测试。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验